2.64 USD
↗ 0.10 (3.74%)LIVE (AS OF 11:39 AM EST)
Ovid Therapeutics Inc. Common Stock (OVID) trades at $2.64 per share. Technicals currently rate "Strong Buy" while our fundamental analysis reads "Neutral". Key drivers include a robust Altman Z-Score, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bullish Golden Cross on the moving averages and bullish moving average alignment. OVID is fairly valued relative to its sector peers based on current multiples.
Technical & fundamental data as of Nov 13, 2026.